“Nano-Biomaterials” – A New Approach Concerning Multi-Drug Resistant Tuberculosis (MDR-TB)

Publisher： Bentham Science Publishers

E-ISSN： 2211-7393|3|1|5-18

ISSN： 2211-7385

Source： Pharmaceutical Nanotechnology, Vol.3, Iss.1, 2015-01, pp. : 5-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bedaquiline: A New Hope to Treat Multi-Drug Resistant Tuberculosis

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 16, 2014-08 ,pp. : 1866-1874

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis

By  

Current Clinical Pharmacology, Vol. 5, Iss. 2, 2010-05 ,pp. : 96-114

Bentham Science Publishers

Access to resources Recommend Favorite

Antitumour Antibiotics with Potent Activity Against Multidrug Resistant (MDR) Staphylococcus aureus: A New Approach to Targeting Resistant Bacteria

By  

Medicinal Chemistry, Vol. 1, Iss. 6, 2005-11 ,pp. : 619-627

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug-resistant TB gets backing from drug giant

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Comprehensive approach for extensively-drug resistant TB

By  

Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite